FDA bioterrorism meeting
This article was originally published in The Tan Sheet
Executive Summary
Proposed regulations on how to implement two sections of the bioterrorism act - registration of food facilities and prior notice of imported food shipments - will be discussed Jan. 29 at a public meeting available via satellite downlink, agency announces in Jan. 9 Federal Register. For more information contact CFSAN's Louis Carson at (301) 436-2130...
You may also be interested in...
Finance Watch: Two SPAC Deals, Two IPOs Take Four Biopharmas Public
Public Company Edition: Mergers with special purpose acquisition corporations may be heating up, but in addition to the Surrozen and Tango SPAC deals Recursion and Biomea launched initial public offerings. Also, Organon sells $5.6bn worth of notes to fund spinout from Merck & Co.
#ClinicalTrialsSoWhite: How Drug Makers Are Using COVID-19 To Improve Trial Diversity
Efforts to improve trial diversity predate COVID-19, but the pandemic’s disproportionate effects on minority communities have brought the issue to the forefront.
A Hundred Drugs Contend: Chinese Biopharma Gains US Foothold
Legend/J&J’s CAR-T cilta-cel and Chi-Med’s surufatinib would follow BeiGene’s Brukinsa, which won FDA approval in November 2019.